 |
Commerzbank Q4 hit by Greek writedown
Germany's second biggest lender takes a $931 million hit on Greek sovereign debt and warns euro zone jitters still threaten earnings. Video
Read
- Putin praises Cold War moles for stealing U.S. nuclear secrets
- Karzai says U.S. officer burned Korans, Obama apologizes
|
- Whitney Houston Open Casket Photo Graces National Enquirer Cover
- 'Seinfeld' Actor in Critical Condition After Apparent Suicide Attempt (Report)
- Rome expands cruise ship probe as bodies found
Johnson & Johnson invests in Israel's LifeBond
TEL AVIV |
TEL AVIV Aug 8 (Reuters) - LifeBond, an Israeli maker of biosurgical products, raised over $20 million in a third round of financing led by Giza Venture Capital and Aurum Ventures, with Johnson & Johnson Development Corp joining the process.
Existing investors including Israeli group Pitango Venture Capital also participated in this round.
LifeBond develops surgical sealants, glues and hemostats intended for preventing leakage and bleeding.
It plans to use the financing to complete pre-clinical and clinical phases of its flagship product, LifeSealGI, a sealant indicated for reinforcement of gastro-intestinal anastomoses.
Post-surgical leakage from anastomoses is a significant risk factor that can result in life threatening complications.
LifeBond anticipates that LifeSealGI will reach the market within the next couple of years, pending regulatory approval. (Reporting by Tova Cohen; Editing by Dan Lalor)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters